Clinical Trial Update: N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD [Phase 2]

View source ↗

Summary

Phase 2 trial investigating N-Acetylcysteine as an adjunct to dialectical behavior therapy for self-injurious behavior in Borderline Personality Disorder was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder
• Self-injurious Behavior

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Yale University | Conditions: Borderline Personality Disorder, Self-Injurious Behavior | Phase 2 | Status: TERMINATED | Results posted: 2013-03-06